Reduced Circulating α-Klotho Levels Are Associated With Elevated Mortality and Arterial Calcifications of Aorta and

Elias Hellou1, Parvin Kalhor1, Ali Babaie1

  • 1Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.

Insights

Lower levels of the protein Klotho are linked to increased vascular calcification and higher mortality risk over 10 years. This suggests Klotho plays a role in aging blood vessels.

Area of Science:

  • Gerontology
  • Vascular Biology
  • Biochemistry

Background:

  • α-Klotho is a protein crucial for vascular health, with declining levels associated with aging-related vascular conditions.
  • Reduced Klotho is linked to arterial stiffness, endothelial dysfunction, and vascular calcification.

Purpose of the Study:

  • To investigate the relationship between circulating Klotho levels, aortoiliac calcification, endothelial progenitor cells, and long-term survival.
  • To explore Klotho's role in the aging vasculature.

Main Methods:

  • Retrospective cohort study of 148 participants.
  • Calcification scored by blinded clinicians using computed tomography.
  • Plasma Klotho measured by ELISA; endothelial progenitor cells quantified by flow cytometry; mortality data from death registry.

Main Results:

  • Lower Klotho levels correlated with increased aortoiliac calcification (r=-0.315, P<0.01).
  • Patients with low calcification had significantly higher Klotho levels (P<0.01).
  • Low Klotho was independently associated with higher 10-year mortality (HR=3.056, P=0.014).

Conclusions:

  • Decreased circulating Klotho levels are associated with greater aortoiliac calcification.
  • Lower Klotho is a predictor of increased 10-year mortality.
  • These findings support Klotho's significant role in vascular aging.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
295